Close
CDMO Safety Testing 2026
Novotech

Sanofi and Snowflake Team Up to Deploy AI-Powered Field Agent Support Tool

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Aragen Backs Renaissance Rare Disease Therapy Launch

Contract research, development, and manufacturing organization (CRDMO) Aragen has...

Eli Lilly and Haisco Pharmaceutical Enter $3Billion+ Deal

Eli Lilly has entered into a multi-program collaboration with...

Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi

Eli Lilly and Company and Hanmi Pharm have officially...
- Advertisement -

Sanofi has partnered with cloud data platform company Snowflake to develop an artificial intelligence-driven tool designed to assist the pharmaceutical giant’s field sales representatives in their day-to-day operations. The collaboration aims to give Sanofi’s field agents faster, more efficient access to business-critical data and insights while they are out in the field, reducing time spent on manual processes and enabling more informed conversations with healthcare professionals.

The AI-powered tool, built on Snowflake’s data cloud infrastructure, is intended to function as an intelligent assistant for Sanofi’s sales force. Rather than requiring field agents to navigate multiple platforms or wait for data to be pulled by back-office teams, the solution brings together relevant information including customer data, product details, and market insights into a single, streamlined interface that representatives can access in real time. The goal is to allow Sanofi field agents to spend less time on administrative tasks and more time engaging meaningfully with physicians, pharmacists, and other healthcare stakeholders.

Snowflake’s involvement in this initiative reflects a broader push within the pharmaceutical and life sciences industry to harness the power of modern data architecture to drive commercial performance. By leveraging Snowflake’s platform, Sanofi is able to centralise and govern its data more effectively while simultaneously enabling the development of AI and machine learning applications on top of that infrastructure. The Sanofi AI field agent tool is positioned as one of the practical outcomes of this deeper investment in data capabilities.

This partnership is part of Sanofi’s wider digital transformation strategy, which has seen the company make substantial commitments to artificial intelligence across multiple functions, including research and development, manufacturing, and commercial operations. The company has previously spoken about its ambition to become an AI-first organisation, and initiatives like this one with Snowflake reflect that ongoing direction.

The collaboration between Sanofi and Snowflake for the AI field agent highlights how pharmaceutical companies are increasingly turning to technology partnerships to modernise their commercial operations. By equipping field representatives with AI-powered tools grounded in reliable, real-time data, Sanofi is working to ensure its sales teams remain competitive in an environment where speed, accuracy, and personalisation are growing priorities across the healthcare sector.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Aragen Backs Renaissance Rare Disease Therapy Launch

Contract research, development, and manufacturing organization (CRDMO) Aragen has...

Eli Lilly and Haisco Pharmaceutical Enter $3Billion+ Deal

Eli Lilly has entered into a multi-program collaboration with...

Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi

Eli Lilly and Company and Hanmi Pharm have officially...

Pharmacogenomics in 2026: From Research Concept to Clinical Workflow

Pharmacogenomics has moved well beyond the research phase. In...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป